Jacob Safier - 10 Apr 2024 Form 4 Insider Report for Orgenesis Inc. (ORGS)

Role
10%+ Owner
Signature
/s/ Jacob Safier
Issuer symbol
ORGS
Transactions as of
10 Apr 2024
Net transactions value
+$624
Form type
4
Filing time
04 Dec 2024, 18:48:38 UTC
Previous filing
14 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORGS Common Stock Purchase $5,948 +10,000 +0.32% $0.5948 3,120,100 10 Apr 2024 By JSAF Holdings, LLC F1, F2
transaction ORGS Common Stock Sale $5,444 -10,000 -0.32% $0.5444 3,110,100 10 Apr 2024 By JSAF Holdings, LLC F1, F2
transaction ORGS Common Stock Purchase $5,135 +10,000 +0.32% $0.5135 3,120,100 16 Apr 2024 By JSAF Holdings, LLC F1, F2
transaction ORGS Common Stock Sale $5,001 -10,000 -0.32% $0.5001 3,110,100 16 Apr 2024 By JSAF Holdings, LLC F1, F2
transaction ORGS Common Stock Purchase $5,800 +10,000 +0.32% $0.5800 3,120,100 24 Jun 2024 By JSAF Holdings, LLC F1, F2
transaction ORGS Common Stock Sale $5,814 -10,000 -0.32% $0.5814 3,110,100 24 Jun 2024 By JSAF Holdings, LLC F1, F2
holding ORGS Common Stock 2,000,000 10 Apr 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORGS Warrant (right to buy) Award $0 +970,873 $0.000000 970,873 21 Aug 2024 Common Stock 970,873 $1.03 Direct F1, F3, F4
transaction ORGS Warrant (right to buy) Award $0 +242,718 $0.000000 242,718 09 Sep 2024 Common Stock 242,718 $1.03 Direct F1, F5, F6
transaction ORGS Warrant (right to buy) Award $0 +242,718 $0.000000 242,718 04 Nov 2024 Common Stock 242,718 $1.03 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jacob Safier is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On September 25, 2024, the Issuer effected a reverse stock split at a ratio of 1-for-10. The share amounts set forth here are presented before giving effect to the reverse stock split.
F2 The Reporting Person is the portfolio manager of the investment in the Issuer by JSAF Holdings, LLC ("JSAF") and may therefore be deemed to beneficially own the shares owned by JSAF. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3 Pursuant to an Amended and Restated Promissory Note, dated as of August 10, 2024, issued by the Issuer to the Reporting Person, the Reporting Person was issued a warrant ("Warrant 1") exercisable for 970,873 shares of the Issuer's Common Stock, subject to adjustment in accordance with the terms thereof.
F4 Other than 53,970 shares currently exercsiable, Warrant 1 is not currently exercisable because it cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934 (the "Exchange Act"), more than 9.99% of the outstanding shares of the Issuer's Common Stock, subject to certain exceptions.
F5 Pursuant to an Amended and Restated Promissory Note, dated as of September 9, 2024, issued by the Issuer to the Reporting Person, the Reporting Person was issued a warrant ("Warrant 2") exercisable for 242,718 shares of the Issuer's Common Stock, subject to adjustment in accordance with the terms thereof.
F6 Warrant 2 is not currently exercisable because it cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person would beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than 9.99% of the outstanding shares of the Issuer's Common Stock, subject to certain exceptions.
F7 Pursuant to an Amended and Restated Promissory Note, dated as of November 4, 2024, issued by the Issuer to the Reporting Person, the Reporting Person was issued a warrant ("Warrant 3") exercisable for 242,718 shares of the Issuer's Common Stock, subject to adjustment in accordance with the terms thereof.
F8 Warrant 3 is not currently exercisable because it cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person would beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than 9.99% of the outstanding shares of the Issuer's Common Stock, subject to certain exceptions.